SCHEMBL751196

SCHEMBL751196

COC(=O)c1ccc2c(c1)COc1ccccc1-2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 2/20 0.57
GAA P10253 2/20 0.57
HPGD P15428 2/20 0.57
MAPK1 P28482 2/20 0.57
HSD17B10 Q99714 2/20 0.57
GLA P06280 1/20 0.57
TSHR P16473 1/20 0.57
CASP1 P29466 1/20 0.57
CASP7 P55210 1/20 0.57
ATM Q13315 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
ROCK2 O75116 11/20 0.54
MAPT P10636 3/20 0.48
TP53 P04637 1/20 0.48
ALOX5 P09917 1/20 0.46
NOTUM Q6P988 1/20 0.46
TRPA1 O75762 1/20 0.45
PDK2 Q15119 1/20 0.44
MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1917980 0.91 ALDH1A1 (0.54) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL20788479 0.90 ROCK2 (0.55) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL30529024 0.90 ROCK2 (0.55) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL24502972 0.84 KDM4E (0.52) KDM4EALDH1A1GAAROCK2MAPK14
SCHEMBL205863 0.84 ROCK2 (0.52) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL205164 0.84 ROCK2 (0.52) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL10923685 0.83 MAPK14 (0.58) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL3029409 0.82 MAPT (0.55) KDM4EALDH1A1GAAHSD17B10ATM
SCHEMBL752471 0.82 SRD5A2 (0.64) KDM4EALDH1A1GAAHPGDMAPK1
SCHEMBL8797606 0.81 ALDH1A1 (0.64) KDM4EALDH1A1GAAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed